Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.
about
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trialsMetformin monotherapy for type 2 diabetes mellitusDipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitusRosiglitazone for type 2 diabetes mellitusPioglitazone for type 2 diabetes mellitusMetformin monotherapy for type 2 diabetes mellitusEffect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsRandomised controlled trial of structured personal care of type 2 diabetes mellitusGlycaemia and vascular effects of type 2 diabetes. Lowering glucose concentrations may not be of any value in itselfEmerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetesEvidence-informed person-centered healthcare part I: do 'cognitive biases plus' at organizational levels influence quality of evidence?Cholesterol paradox: a correlate does not a surrogate make.What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes.Cholinesterase inhibitors: drugs looking for a disease?Why were the benefits of tPA exaggerated?Complexity, leadership, and management in healthcare organisationsMetformin's contraindications should be contraindicated.Is the randomized clinical trial the gold standard of research?Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.Medical treatment of diabetic retinopathy.Six 'biases' against patients and carers in evidence-based medicineEfficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trialsCardiovascular prevention in type 2 diabetic patients: review of efficacious treatments.Exploring the understanding of evidence-based concepts in people with type 2 diabetesIntervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions.Lipid and other management to improve arterial disease and survival in end stage renal disease.Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.Interpretation of randomised trials is indeed open to debate.Managing hyperglycaemia.Seeing what you want to see in randomised controlled trials. Authors' choice of study was ill informedDissemination of 'patient-oriented evidence that matters' on the Internet: the case of Type 2 diabetes treatment.Improvement of glycaemic control by nateglinide decreases systolic blood pressure in drug-naive patients with type 2 diabetes.EBM: a narrow and obsessive methodology that fails to meet the knowledge needs of a complex adaptive clinical world: a commentary on Djulbegovic, B., Guyatt, G. H. & Ashcroft, R. E. (2009) Cancer Control, 16, 158-168.Doctor's Dilemma.The inverse benefit law: how drug marketing undermines patient safety and public health.
P2860
Q21144611-AE0E5D0A-E933-46F3-8C3A-1198985277E3Q24187392-A14D26E6-01A8-4B44-8E60-529257091BEBQ24243196-8C9AC65A-FFA1-474A-A8AB-749642FCEC23Q24243875-62C740BF-6638-4003-90BA-A883A5302D9CQ24244321-452655DE-C45D-4FFF-A7FB-EEA439F74812Q24246552-ED7C8C43-A65E-461B-A790-F71B59FA9386Q24628988-851E20DF-7957-455D-BCCE-EC8FBDC6296FQ28362638-14AED48B-B8D4-4058-8A18-3B0A03E4557DQ28366185-23874242-990C-4096-BBCD-F4A59EC89553Q28762629-6F340C42-D8A3-4742-B4BE-38D6A7096190Q30368983-AD704225-BB96-4FC5-BA1C-478A9AA426B1Q30396673-EC17C637-B05B-4099-BCAD-375964451B26Q30452941-7D30D653-B55E-4FB2-8074-C7B031926397Q33238993-A32F845F-9AA9-4DEF-948D-FDC3AF18A97CQ33729791-14929809-E040-48E2-BF91-4A298AFF54F4Q33807311-60C56EDA-C8BF-4093-A90B-E7DB0141789BQ33920606-5D07165C-C5FA-48B6-8430-B580D37514ACQ34432594-7B0993F9-9E85-4372-A6BF-79B585D1079DQ35042647-370DBE01-8361-4C8D-A877-36660C976C07Q35175679-0C8AF287-9BD2-4890-9A22-3B3C800013C0Q35760715-48B90899-20A6-4D80-96A1-B700554251B0Q36071183-D863B17F-F932-41F7-96E3-1D96EE7D65B0Q36093161-FB4CCF36-8802-413C-8504-9D40E6BAE4BCQ36283932-86217A5C-69B6-438C-B7EB-00EFEC40FBCDQ36329181-E8717DD2-E6DE-4EC9-939E-AA6EA2F67414Q39097856-5A2B22BB-F49B-4143-A0AD-BB0EDF0F1004Q41145183-BE30967C-B565-4400-AB31-23762C0B0533Q42609542-052DC6A9-4B73-491B-8B9D-B0286CAFE25FQ42736336-C9A12B89-4B5C-47B5-A9C6-DBD7A8894FCFQ42768986-416907EE-72A8-46B0-8BBD-EE5FB3C45E4BQ46504532-19881213-ECCB-46CD-BC47-41A22E057658Q46766438-6E5144DE-EFB3-4178-A787-6438DA6C089DQ48845833-A94FD664-0FA8-4518-AC51-3F1C2ECBEBFAQ51037940-692592EE-CC2A-4875-9D96-956A8626DE3CQ53054239-25697774-3200-45E4-9849-85A7F1B74191
P2860
Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Seeing what you want to see in ...... om prospective diabetes study.
@ast
Seeing what you want to see in ...... om prospective diabetes study.
@en
type
label
Seeing what you want to see in ...... om prospective diabetes study.
@ast
Seeing what you want to see in ...... om prospective diabetes study.
@en
prefLabel
Seeing what you want to see in ...... om prospective diabetes study.
@ast
Seeing what you want to see in ...... om prospective diabetes study.
@en
P2860
P1433
P1476
Seeing what you want to see in ...... om prospective diabetes study.
@en
P2093
J McCormack
P2860
P304
P356
10.1136/BMJ.320.7251.1720
P407
P577
2000-06-01T00:00:00Z